Preliminary results of 5% immiquimod cream in the primary treatment of vulva intraepithelial neoplasia grade 2/3
Authors:
- Wendy HicksWHWendy Hicks
- Chantal MenardCMChantal Menard
- Laura HopkinsLHLaura Hopkins
- Michael Fung Kee FungMFMichael Fung Kee Fung
- 1 February 2006
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 194 (2) , 377-380
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patientsGynecologic Oncology, 2005
- Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studiesJournal of the American Academy of Dermatology, 2004
- Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasiaGynecologic Oncology, 2004
- Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effectEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2003
- The Effects of 5% Imiquimod Cream on High-Grade Vulval Intraepithelial NeoplasiaGynecologic Oncology, 2002
- Successful topical immunotherapy of bowenoid papulosis with imiquimod.British Journal of Dermatology, 2001
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998
- Vulvar intraepithelial neoplasia with superficially invasive carcinoma of the vulvaBJOG: An International Journal of Obstetrics & Gynaecology, 1996
- Long-Term Interferon-Alpha Therapy Induces Autoantibodies against EpidermisDermatology, 1996
- Human papillomavirus type‐16‐related DNA in genital Bowen's disease and in bowenoid papulosisInternational Journal of Cancer, 1983